These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23480245)

  • 1. Surveillance of diversion and nonmedical use of extended-release prescription amphetamine and oral methylphenidate in the United States.
    Sembower MA; Ertischek MD; Buchholtz C; Dasgupta N; Schnoll SH
    J Addict Dis; 2013; 32(1):26-38. PubMed ID: 23480245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of adolescent prescription drug abuse and misuse using the Researched Abuse Diversion and Addiction-related Surveillance (RADARS(®)) System.
    Zosel A; Bartelson BB; Bailey E; Lowenstein S; Dart R
    J Am Acad Child Adolesc Psychiatry; 2013 Feb; 52(2):196-204.e2. PubMed ID: 23357446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential for misuse and abuse of medications in ADHD: a review.
    Clemow DB; Walker DJ
    Postgrad Med; 2014 Sep; 126(5):64-81. PubMed ID: 25295651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. School-based administration of ADHD drugs decline, along with diversion, theft, and misuse.
    Dupont RL; Bucher RH; Wilford BB; Coleman JJ
    J Sch Nurs; 2007 Dec; 23(6):349-52. PubMed ID: 18052521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonmedical use of prescription ADHD stimulant medications among adults in a substance abuse treatment population: early findings from the NAVIPPRO surveillance system.
    Cassidy TA; McNaughton EC; Varughese S; Russo L; Zulueta M; Butler SF
    J Atten Disord; 2015 Apr; 19(4):275-83. PubMed ID: 23900405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of methylphenidate use and assessment of its abuse and diversion in two French administrative areas using a proxy of deviant behaviour determined from a reimbursement database: main trends from 2005 to 2008.
    Frauger E; Pauly V; Natali F; Pradel V; Reggio P; Coudert H; Thirion X; Micallef J
    CNS Drugs; 2011 May; 25(5):415-24. PubMed ID: 21476612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescriptions, nonmedical use, and emergency department visits involving prescription stimulants.
    Chen LY; Crum RM; Strain EC; Alexander GC; Kaufmann C; Mojtabai R
    J Clin Psychiatry; 2016 Mar; 77(3):e297-304. PubMed ID: 26890573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in the consumption of attention deficit hyperactivity disorder medications in Castilla y León (Spain): changes in the consumption pattern following the introduction of extended release methylphenidate.
    Treceño C; Martín Arias LH; Sáinz M; Salado I; García Ortega P; Velasco V; Jimeno N; Escudero A; Velasco A; Carvajal A
    Pharmacoepidemiol Drug Saf; 2012 Apr; 21(4):435-41. PubMed ID: 22253017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADHD Medication Trends in Turkey: 2009-2013.
    Öner Ö; Yilmaz EŞ; Karadağ H; Vural M; Vural EH; Akbulat A; Gürsöz H; Türkçapar H; Kerman S
    J Atten Disord; 2017 Dec; 21(14):1192-1197. PubMed ID: 24554298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of adherence measures with different stimulants among children and adolescents.
    Sanchez RJ; Crismon ML; Barner JC; Bettinger T; Wilson JP
    Pharmacotherapy; 2005 Jul; 25(7):909-17. PubMed ID: 16006269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of lisdexamfetamine and dextroamphetamine exposures reported to U.S. poison centers.
    Kaland ME; Klein-Schwartz W
    Clin Toxicol (Phila); 2015 Jun; 53(5):477-85. PubMed ID: 25832473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in stimulant dispensing by age, sex, state of residence, and prescriber specialty - United States, 2014-2019.
    Board AR; Guy G; Jones CM; Hoots B
    Drug Alcohol Depend; 2020 Dec; 217():108297. PubMed ID: 32961454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Young Children with Attention-Deficit/Hyperactivity Disorder and/or Disruptive Behavior Disorders Are More Frequently Prescribed Alpha Agonists Than Stimulants.
    Mittal S; Boan AD; Kral MC; Lally MD; van Bakergem K; Macias MM; LaRosa A
    J Child Adolesc Psychopharmacol; 2020 Mar; 30(2):81-86. PubMed ID: 31621385
    [No Abstract]   [Full Text] [Related]  

  • 15. Changing Epidemiology of Methylphenidate Prescriptions in the Community: A Multifactorial Model.
    Jaber L; Rigler S; Shuper A; Diamond G
    J Atten Disord; 2017 Dec; 21(14):1143-1150. PubMed ID: 24776713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription of methylphenidate to children and youth, 1990-1996.
    Miller AR; Lalonde CE; McGrail KM; Armstrong RW
    CMAJ; 2001 Nov; 165(11):1489-94. PubMed ID: 11762572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric ADHD Medication Exposures Reported to US Poison Control Centers.
    King SA; Casavant MJ; Spiller HA; Hodges NL; Chounthirath T; Smith GA
    Pediatrics; 2018 Jun; 141(6):. PubMed ID: 29784754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Prescription Trend Analysis of Methylphenidate: Relation to Study Reports on Efficacy.
    Sluiter MN; de Vries YA; Koning LG; Hak E; Bos JHJ; Schuiling-Veninga CCM; Batstra L; Doornenbal JM; de Jonge P
    Adm Policy Ment Health; 2020 Mar; 47(2):291-299. PubMed ID: 31620909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of food on early drug exposure from extended-release stimulants: results from the Concerta, Adderall XR Food Evaluation (CAFE) Study.
    Auiler JF; Liu K; Lynch JM; Gelotte CK
    Curr Med Res Opin; 2002; 18(5):311-6. PubMed ID: 12240794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.